Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
BN 50739 is an active compound
Inhibitory effects of curcumenol on human liver cytochrome P450 enzymes
15-pentaoxaoctadecanoic acid
Dynorphin A also serve as an agonist for other opioid receptors
GSK1016790A is a potent and selective transient receptor potential vanilloid 4 (TRPV4) channel agonist
(-)-Cevimeline hydrochloride hemihydrate Catalog No.:M34745-C BN 50739 is an active( ) Cevimeline hydrochloride hemihydrate (( ) SNI 2011), a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI 2011 was also evaluated with rat and dog liver
US$ 44.00
US$ 41.00
US$ 88.00
US$ 43.00
US$ 49.00
US$ 35.00
US$ 40.00
US$ 81.00
US$ 44.00
US$ 49.00